Role of PET/CT and Therapy Management of Pancreatic Neuroendocrine Tumors
Pancreatic neuroendocrine neoplasms (panNENs) are heterogeneous neoplasms with neuroendocrine differentiation that show peculiar clinical and histomorphological features, with variable prognosis. In recent years, advances in knowledge regarding the pathophysiology and heterogeneous clinical presenta...
Main Authors: | Diletta Calabrò, Giulia Argalia, Valentina Ambrosini |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/10/12/1059 |
Similar Items
-
Results of a Prospective Trial to Compare <sup>68</sup>Ga-DOTA-TATE with SiPM-Based PET/CT vs. Conventional PET/CT in Patients with Neuroendocrine Tumors
by: Lucia Baratto, et al.
Published: (2021-05-01) -
Cost-Effectiveness Analysis of <sup>68</sup>Ga DOTA-TATE PET/CT, <sup>111</sup>In-Pentetreotide SPECT/CT and CT for Diagnostic Workup of Neuroendocrine Tumors
by: Matthias Frank Froelich, et al.
Published: (2021-02-01) -
CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas
by: Alexander Weich, et al.
Published: (2021-03-01) -
[<sup>68</sup>Ga]Ga-Pentixafor for PET Imaging of Vascular Expression of CXCR-4 as a Marker of Arterial Inflammation in HIV-Infected Patients: A Comparison with <sup>18</sup>F[FDG] PET Imaging
by: Ismaheel O. Lawal, et al.
Published: (2020-12-01) -
[<sup>68</sup>Ga]Ga-DOTA-TOC: The First FDA-Approved <sup>68</sup>Ga-Radiopharmaceutical for PET Imaging
by: Ute Hennrich, et al.
Published: (2020-03-01)